A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether THR-184 when administered around the time
of cardiac surgery that requires cardiopulmonary bypass can prevent or ameliorate the
development of acute kidney injury.